DOI: 10.11606/d.9.2021.tde-05082021-111631
|View full text |Cite
|
Sign up to set email alerts
|

Risk assessment of potentially mutagenic impurities in anti-hypertensive drug products approved in Brazil

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles